2m 2m 2m 2m 2m 2m 2m
INHIBIKASE THRP (IKT)
NASDAQ
$1.58-$0.05 (-3.01%)
Price as of Nov 12, 2026 8:52 AM EST- $227.4MMarket Cap
- 0.62%1-Year Change
- BiotechnologyIndustry
INHIBIKASE THRP (IKT)
$1.58-$0.05 (-3.01%)
Earnings Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -28.16% | ||
12-Month Momentum | 7.32% | ||
3-Month Risk Adjusted Momentum | -146.94% | ||
12-Month Risk Adjusted Momentum | 12.51% |
True Yield
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.03% |
Financial Health Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -4 |